Abound Bio Employee Directory
Biotechnology ResearchPennsylvania, United States0-1 Employees
Abound Bio is a biotechnology research company focused on developing antibody-based therapeutics for cancer and infectious diseases. Its work aims to address unmet medical needs by leveraging therapeutic antibodies to create novel biological treatments. The company has been led by experts in therapeutic antibodies, infectious disease, and cancer, with a track record in biotherapeutics development, licensing, and partnerships. Based in Pittsburgh, Pennsylvania, Abound Bio has operated as a distinct entity with a history of collaboration in the field, including a 2022 acquisition by Galapagos, after which updates and news have been shared on the Galapagos platform. A recent development noted in public sources references a multiyear collaboration and license agreement to research CAR T therapies, indicating continued activity in antibody-directed cellular approaches within the broader oncology space.